337

ANCESTRY-SPECIFIC GENETIC EFFECTS IDENTIFIED IN A COHORT OF HISPANICS WITH INFLAMMATORY BOWEL DISEASE

Date
May 19, 2024
Explore related products in the following collection:

Background: Although incidence of Inflammatory Bowel Disease (IBD) is rising in underrepresented populations, including Hispanics, genetic studies of IBD have primarily focused on Northern European ancestral populations. The genetic admixture of Hispanics provides a unique opportunity to examine the ancestral origins of risk and may further elucidate the underlying pathophysiology of IBD. We sought to determine whether heterogeneity of effect exists by ancestral origin for previously identified IBD susceptibility alleles and to identify novel alleles which may be ancestry-specific.
Methods: Whole Genome Sequence (WGS) data were available for 7273 Hispanic subjects including 1659 cases [938 Crohn’s Disease (CD), 684 Ulcerative Colitis (UC), 37 other IBD] and 5614 controls. Following stringent quality control, WGS data were phased with BEAGLE and local ancestry was computed with RFMixV2. Genome-wide association was performed with Tractor to obtain ancestry-specific effect size estimates for alleles from an African (AFR), European (EUR), and Amerindian (AI/AN) origin.
Results: For CD, the strongest associations (p < 1.0E-07) were identified for alleles residing on a EUR haplotype within the previously identified NOD2 (6 variants), IL23R (55), CYLD (1), NKD1 (2), and HLA-DRA (1) loci. All identified variants had low frequency (<1%) among alleles from an AFR or AI/AN origin, except for 48 of the IL23R variants which had frequency >10% amongst AFR or AI/AN alleles yet showed no evidence for association within those ancestral subsets. For alleles residing on an AFR or AI/AN haplotype, novel associations (p < 1.0E-06) were seen both within (i.e. KIAA119 for AFR, R2 < 0.2 with the previously identified variant) and outside of previously identified loci (i.e. GAD2 for AI/AN, >500 KB from a previously identified variant). Similarly for UC, the strongest associations (p < 1.0E-07) were identified for alleles residing on a EUR haplotype within the previously identified HLA locus (22 variants on chr6 from 31-33 MB), where all but one (SKIV2L) had low frequency among alleles from an AFR or AI/AN origin. For alleles residing on an AFR or AI/AN haplotype, novel associations were again seen both within (i.e. DOCK8 for AFR) and outside of previously identified loci (i.e. CSMD1 for AFR).
Conclusions: We have demonstrated the power of ancestry-informed regression to identify novel AFR and AI/AN specific risk alleles both within and outside of previously identified IBD loci. We have additionally shown that some previously identified IBD alleles are observed only on a EUR haplotype while others are observed across ancestral backgrounds but only exert an effect on IBD amongst the EUR allele subset. These findings highlight the important role genetic ancestry may play in elucidating the biological underpinnings of IBD and facilitating treatment for all patient populations.

Speakers

Speaker Image for Dermot P.B. Mcgovern
Cedars-Sinai Medical Center
Speaker Image for Oriana Damas
University of Miami Miller School of Medicine
Speaker Image for Judy Cho
Icahn School of Medicine at Mount Sinai
Speaker Image for Maria Abreu
University of Miami Miller School of Medicine

Tracks

Related Products

Thumbnail for IDENTIFYING CAUSAL LINKS BETWEEN PLASMA PROTEOMICS AND INFLAMMATORY BOWEL DISEASES (IBD) VIA INTEGRATION OF UK BIOBANK (UKBB) PQTL DATASET AND IBD GWAS
IDENTIFYING CAUSAL LINKS BETWEEN PLASMA PROTEOMICS AND INFLAMMATORY BOWEL DISEASES (IBD) VIA INTEGRATION OF UK BIOBANK (UKBB) PQTL DATASET AND IBD GWAS
BACKGROUND: With the comprehensive characterization of 14,287 primary genetic association with 2,923 plasma proteins in 54,219 UKBB participants, the recently published UKBB pQTL dataset provides a rich resource to elucidate the biological mechanisms underlying proteo-genomic discoveries and accele…
Thumbnail for A CLINICAL SCORE FOR UC2CD, A NOVEL SUBGROUP IN INFLAMMATORY BOWEL DISEASES (IBD) WITH DISTINCT SEROLOGICAL, GENETIC AND CLINICAL FEATURES
A CLINICAL SCORE FOR UC2CD, A NOVEL SUBGROUP IN INFLAMMATORY BOWEL DISEASES (IBD) WITH DISTINCT SEROLOGICAL, GENETIC AND CLINICAL FEATURES
BACKGROUND: Previously we identified that patients with initial diagnosis of Ulcerative Colitis (UC) but subsequently had a diagnosis change to Crohn’s Disease (CD) (UC2CD) are a unique IBD subgroup with distinct serological, genetic and clinical features, including non-response to anti-TNF treatme…
Thumbnail for INTERVALS OF A PLANT-BASED, LOW-CALORIE DIET IMPROVE CLINICAL SYMPTOMS COMPARED WITH USUAL DIET IN PATIENTS INITIATING ADVANCED THERAPIES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS
INTERVALS OF A PLANT-BASED, LOW-CALORIE DIET IMPROVE CLINICAL SYMPTOMS COMPARED WITH USUAL DIET IN PATIENTS INITIATING ADVANCED THERAPIES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS
Introduction: Diet plays an important role in ulcerative colitis (UC) yet there are no studies examining the role of diet as adjunctive therapy to medication…
Thumbnail for BACTERIAL QUORUM SENSING MOLECULES MIRROR RISK OF COLITIS ASSOCIATED CANCER IN UC AND PROMOTE EXPERIMENTAL COLITIS-ASSOCIATED NEOPLASIA.
BACTERIAL QUORUM SENSING MOLECULES MIRROR RISK OF COLITIS ASSOCIATED CANCER IN UC AND PROMOTE EXPERIMENTAL COLITIS-ASSOCIATED NEOPLASIA.
BACKGROUND: Ulcerative colitis (UC) is associated with dysbiosis and an increased risk of colon cancer over time. Non-invasive methods of identifying UC patients at risk of developing CAC do not exist…